AIM ImmunoTech Inc. (NYSE:AIM) COO Peter W. Rodino III Buys 30,865 Shares

AIM ImmunoTech Inc. (NYSE:AIM) COO Peter W. Rodino III purchased 30,865 shares of the business’s stock in a transaction dated Monday, May 6th. The shares were bought at an average price of $0.41 per share, with a total value of $12,654.65. Following the purchase, the chief operating officer now directly owns 212,583 shares of the company’s stock, valued at $87,159.03. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

AIM ImmunoTech Stock Performance

AIM stock opened at $0.43 on Wednesday. AIM ImmunoTech Inc. has a one year low of $0.32 and a one year high of $0.75. The company has a fifty day moving average of $0.43 and a 200-day moving average of $0.44. The stock has a market capitalization of $21.57 million, a PE ratio of -0.71 and a beta of -0.11.

AIM ImmunoTech (NYSE:AIM) last announced its quarterly earnings data on Friday, March 29th. The company reported ($0.26) earnings per share for the quarter. The business had revenue of $0.07 million during the quarter. AIM ImmunoTech had a negative net margin of 14,337.62% and a negative return on equity of 121.69%.

About AIM ImmunoTech

AIM ImmunoTech Inc, an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS).